Enanta Pharmaceuticals (ENTA) Short Interest Ratio & Short Volume $7.33 -0.45 (-5.78%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$7.36 +0.03 (+0.46%) As of 03/3/2025 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Enanta Pharmaceuticals Short Interest DataEnanta Pharmaceuticals (ENTA) has a short interest of 3.57 million shares, representing 18.01% of the float (the number of shares available for trading by the public). This marks a 6.25% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.2, indicating that it would take 6.2 days of the average trading volume of 548,524 shares to cover all short positions.Current Short Interest3,570,000 sharesPrevious Short Interest3,360,000 sharesChange Vs. Previous Month+6.25%Dollar Volume Sold Short$25.49 millionShort Interest Ratio6.2 Days to CoverLast Record DateFebruary 15, 2025Outstanding Shares21,333,000 sharesFloat Size19,820,000 sharesShort Percent of Float18.01%Today's Trading Volume196,859 sharesAverage Trading Volume548,524 sharesToday's Volume Vs. Average36% Short Selling Enanta Pharmaceuticals? Sign up to receive the latest short interest report for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENTA Short Interest Over TimeENTA Days to Cover Over TimeENTA Percentage of Float Shorted Over Time Enanta Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/20253,570,000 shares $25.49 million +6.3%18.0%6.2 $7.14 1/31/20253,360,000 shares $17.17 million +4.0%16.9%6.9 $5.11 1/15/20253,230,000 shares $15.57 million -3.6%16.4%7.3 $4.82 12/31/20243,350,000 shares $19.26 million -0.6%17.0%8.8 $5.75 12/15/20243,370,000 shares $20.32 million +4.3%17.1%12.2 $6.03 11/30/20243,230,000 shares $27.78 million -4.4%16.4%15.2 $8.60 11/15/20243,380,000 shares $32.21 million -1.7%17.2%20 $9.53 10/31/20243,440,000 shares $38.68 million +0.3%17.5%22 $11.25 10/15/20243,430,000 shares $40.03 million +14.7%17.4%20.7 $11.67 9/30/20242,990,000 shares $30.98 million +2.4%15.2%16.5 $10.36 Get the Latest News and Ratings for ENTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/20242,920,000 shares $36.30 million +0.3%14.8%16.9 $12.43 8/31/20242,910,000 shares $37.48 million -1.7%14.8%16.7 $12.88 8/15/20242,960,000 shares $36.29 million +5.7%15.0%16 $12.26 7/31/20242,800,000 shares $41.33 million -3.8%14.2%15.7 $14.76 7/15/20242,910,000 shares $48.13 million -3.3%14.8%16.6 $16.54 6/30/20243,010,000 shares $39.04 million +9.1%15.3%18.3 $12.97 6/15/20242,760,000 shares $35.44 million No Change14.0%15.3 $12.84 5/31/20242,760,000 shares $34.42 million -1.4%14.0%14.7 $12.47 5/15/20242,800,000 shares $37.35 million +0.7%14.2%14.5 $13.34 4/30/20242,780,000 shares $38.20 million +1.5%14.2%12.5 $13.74 4/15/20242,740,000 shares $44.25 million No Change13.9%12 $16.15 3/31/20242,740,000 shares $47.84 million +13.7%13.9%10.4 $17.46 3/15/20242,410,000 shares $34.25 million +15.3%12.3%9.2 $14.21 2/29/20242,090,000 shares $30.03 million -5.4%10.6%8 $14.37 2/15/20242,210,000 shares $29.30 million +20.1%11.2%8.2 $13.26 1/31/20241,840,000 shares $22.36 million +15.7%9.3%6.5 $12.15 1/15/20241,590,000 shares $17.82 million +2.6%8.1%5.4 $11.21 12/31/20231,550,000 shares $14.59 million -13.9%7.9%5.4 $9.41 12/15/20231,800,000 shares $16.81 million +22.5%9.2%6.4 $9.34 11/30/20231,470,000 shares $13.73 million -2.7%7.5%3.4 $9.34 11/15/20231,510,000 shares $13.21 million +12.7%7.7%3.3 $8.75 10/31/20231,340,000 shares $12.09 million +3.9%6.9%3.1 $9.02 10/15/20231,290,000 shares $12.42 million +8.4%6.6%3 $9.63 9/30/20231,190,000 shares $13.29 million -42.0%6.8%2.9 $11.17 9/15/20232,050,000 shares $26.10 million +22.0%10.5%5.2 $12.73 8/31/20231,680,000 shares $24.95 million +16.7%8.6%6 $14.85 8/15/20231,440,000 shares $22.82 million No Change7.4%6.4 $15.85 7/31/20231,440,000 shares $27.32 million +5.9%7.4%6 $18.97 7/15/20231,360,000 shares $26.14 million +14.3%7.0%5.9 $19.22 6/30/20231,190,000 shares $25.47 million +47.3%6.2%5.3 $21.40$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. 6/15/2023808,100 shares $19.54 million +2.3%4.2%3.7 $24.18 5/31/2023789,600 shares $18.54 million +18.2%4.1%3.9 $23.48 5/15/2023667,800 shares $17.28 million -6.4%3.5%3.4 $25.87 4/30/2023713,500 shares $25.36 million -2.4%3.7%3.8 $35.55 4/15/2023730,800 shares $26.70 million +4.8%3.8%4.2 $36.53 3/31/2023697,100 shares $28.19 million -22.6%3.6%3.9 $40.44 3/15/2023900,100 shares $40.06 million +20.0%4.7%5.3 $44.51 2/28/2023750,300 shares $36.39 million -8.4%3.9%4.8 $48.50 2/15/2023819,500 shares $41.12 million -3.8%4.3%5.1 $50.18 1/31/2023851,400 shares $45.45 million +0.4%4.4%5.5 $53.38 1/15/2023847,700 shares $43.62 million -1.6%4.4%5 $51.46 12/30/2022861,500 shares $40.08 million -6.0%4.5%5 $46.52 12/15/2022916,400 shares $40.17 million -11.9%4.8%5.1 $43.84 11/30/20221,040,000 shares $45.54 million +4.2%5.4%5.4 $43.79 11/15/2022998,400 shares $47.14 million -4.0%5.2%4.9 $47.22 10/31/20221,040,000 shares $46.91 million -17.5%5.4%5.1 $45.11 10/15/20221,260,000 shares $59.16 million -2.3%6.5%6 $46.95 9/30/20221,290,000 shares $66.91 million -5.2%6.7%6.4 $51.87 9/15/20221,360,000 shares $78.77 million -8.1%7.0%6.1 $57.92 8/31/20221,480,000 shares $90.10 million -3.3%7.7%6.1 $60.88 8/15/20221,530,000 shares $107.80 million -8.9%7.9%6.1 $70.46 7/31/20221,680,000 shares $92.65 million +3.1%8.7%5.8 $55.15 7/15/20221,630,000 shares $83.64 million -1.8%8.4%5.9 $51.31 6/30/20221,660,000 shares $78.47 million +5.7%8.6%5.8 $47.27 6/15/20221,570,000 shares $62.80 million +6.1%10.7%5.8 $40.00 5/31/20221,480,000 shares $59.10 million +10.5%7.7%6.2 $39.93 5/15/20221,340,000 shares $66.84 million +10.7%6.9%5.5 $49.88 4/30/20221,210,000 shares $77.92 million +9.0%6.3%5.6 $64.40 4/15/20221,110,000 shares $82.42 million -5.9%5.8%5.2 $74.25 3/31/20221,180,000 shares $83.99 million +9.3%6.1%5.4 $71.18 3/15/20221,080,000 shares $70.87 million +21.9%5.6%5.1 $65.62 2/28/2022886,300 shares $62.41 million +13.7%4.6%4 $70.42 2/15/2022779,800 shares $48.51 million -16.5%4.1%3.5 $62.21 1/31/2022933,700 shares $55.48 million +28.6%5.2%4.3 $59.42 1/15/2022726,100 shares $43.57 million +4.0%N/A0 $60.00 12/31/2021697,900 shares $52.19 million -2.4%3.9%3.5 $74.78 12/15/2021715,300 shares $52.22 million +5.4%4.0%3.6 $73.00 11/30/2021678,900 shares $59.93 million -0.3%3.8%3.7 $88.28 11/15/2021681,000 shares $61.21 million -36.9%3.8%4 $89.88 10/29/20211,080,000 shares $92.72 million -32.1%6.1%6.7 $85.85 10/15/20211,590,000 shares $113.64 million -9.7%8.9%10.8 $71.47 9/30/20211,760,000 shares $99.99 million -2.8%9.9%11.8 $56.81 9/15/20211,810,000 shares $106.16 million -7.2%10.1%11.7 $58.65 8/31/20211,950,000 shares $111.54 million -8.9%10.9%12 $57.20 8/13/20212,140,000 shares $100.90 million +4.9%12.0%13.8 $47.15 7/30/20212,040,000 shares $86.19 million +9.1%11.4%13.8 $42.25 7/15/20211,870,000 shares $78.73 million +7.5%10.5%13.5 $42.10 6/30/20211,740,000 shares $76.58 million -7.0%9.8%13.4 $44.01 6/15/20211,870,000 shares $89.57 million -1.6%10.5%15.6 $47.90 5/28/20211,900,000 shares $92.45 million -4.0%10.6%16.9 $48.66$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. 5/14/20211,980,000 shares $99.59 million -2.5%11.1%15.3 $50.30 4/30/20212,030,000 shares $104.24 million -5.1%11.4%14.8 $51.35 4/15/20212,140,000 shares $108.39 million -2.7%12.0%14.6 $50.65 3/31/20212,200,000 shares $105.75 million +1.4%12.3%14.4 $48.07 3/15/20212,170,000 shares $113.25 million +0.5%12.2%13.2 $52.19 2/26/20212,160,000 shares $109.25 million +1.4%12.1%13.1 $50.58 2/12/20212,130,000 shares $114.66 million -9.0%12.0%13.4 $53.83 1/29/20212,340,000 shares $107.83 million -1.7%13.2%14.8 $46.08 1/15/20212,380,000 shares $115.05 million -1.2%13.4%14.3 $48.34 12/31/20202,410,000 shares $100.11 million +5.2%13.6%14.3 $41.54 12/15/20202,290,000 shares $97.33 million -3.0%12.9%13.5 $42.50 11/30/20202,360,000 shares $101.24 million -2.9%13.4%13.7 $42.90 11/15/20202,430,000 shares $109.64 million -2.0%13.7%13.9 $45.12 10/30/20202,480,000 shares $108.92 million +15.4%14.0%14.2 $43.92 10/15/20202,150,000 shares $95.78 million +3.4%12.1%12.5 $44.55 9/30/20202,080,000 shares $95.22 million -2.8%11.7%12.7 $45.78 9/15/20202,140,000 shares $100.07 million +5.4%12.1%12.6 $46.76 8/31/20202,030,000 shares $105.95 million +4.1%11.5%12.5 $52.19 8/14/20201,950,000 shares $95.08 million -0.5%11.0%12.2 $48.76 7/31/20201,960,000 shares $89.87 million +3.2%11.1%12.2 $45.85 7/15/20201,900,000 shares $98.17 million +2.2%10.8%12.2 $51.67 6/30/20201,860,000 shares $91.21 million +10.7%10.5%11.7 $49.04 6/15/20201,680,000 shares $81.51 million +5.0%9.5%10.4 $48.52 5/29/20201,600,000 shares $82.56 million +0.6%9.1%8.2 $51.60 5/15/20201,590,000 shares $85.35 million -0.6%9.0%7.4 $53.68 4/30/20201,600,000 shares $78.46 million -8.6%9.1%7.1 $49.04 4/15/20201,750,000 shares $92.09 million -2.8%10.0%7.5 $52.62 3/31/20201,800,000 shares $96.48 million -5.5%10.2%7.2 $53.60 3/13/20201,903,800 shares $100.98 million -1.9%10.8%6.6 $53.04 ENTA Short Interest - Frequently Asked Questions What is Enanta Pharmaceuticals' current short interest? Short interest is the volume of Enanta Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of February 15th, investors have sold 3,570,000 shares of ENTA short. 18.01% of Enanta Pharmaceuticals' shares are currently sold short. Learn More on Enanta Pharmaceuticals' current short interest. What is a good short interest ratio for Enanta Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENTA shares currently have a short interest ratio of 6.0. Learn More on Enanta Pharmaceuticals's short interest ratio. Which institutional investors are shorting Enanta Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Enanta Pharmaceuticals: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Enanta Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.01% of Enanta Pharmaceuticals' floating shares are currently sold short. Is Enanta Pharmaceuticals' short interest increasing or decreasing? Enanta Pharmaceuticals saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 3,570,000 shares, an increase of 6.3% from the previous total of 3,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Enanta Pharmaceuticals' float size? Enanta Pharmaceuticals currently has issued a total of 21,333,000 shares. Some of Enanta Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enanta Pharmaceuticals currently has a public float of 19,820,000 shares. How does Enanta Pharmaceuticals' short interest compare to its competitors? 18.01% of Enanta Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Enanta Pharmaceuticals: Anavex Life Sciences Corp. (31.97%), Nuvation Bio Inc. (11.58%), Relay Therapeutics, Inc. (9.86%), Tyra Biosciences, Inc. (11.92%), Sana Biotechnology, Inc. (35.68%), Dianthus Therapeutics, Inc. (26.91%), GH Research PLC (7.91%), Valneva SE (0.05%), Arbutus Biopharma Co. (3.96%), Pharming Group (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks. What does it mean to sell short Enanta Pharmaceuticals stock? Short selling ENTA is an investing strategy that aims to generate trading profit from Enanta Pharmaceuticals as its price is falling. ENTA shares are trading down $0.45 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enanta Pharmaceuticals? A short squeeze for Enanta Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENTA, which in turn drives the price of the stock up even further. How often is Enanta Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENTA, twice per month. The most recent reporting period available is February, 15 2025. More Short Interest Resources from MarketBeat Related Companies Anavex Life Sciences Short Interest Data Nuvation Bio Short Interest Data Relay Therapeutics Short Interest Data Tyra Biosciences Short Interest Data Sana Biotechnology Short Interest Data Dianthus Therapeutics Short Interest Data GH Research Short Interest Data Valneva Short Interest Data Arbutus Biopharma Short Interest Data Pharming Group Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENTA) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enanta Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enanta Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENTA Stock Alerts